Cartesian Therapeutics, Inc. — Director's Dealing 2019

Mar 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2019-01-25

Reporting Person: Farokhzad Omid (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-01-25	Common Stock	P	83333	$1.50	Acquired	83333	Indirect

Footnotes

F1: These securities are held by SAF-BND Trust, for which the Reporting Person's spouse serves as a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.